Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: CycEVA study

Vaccine

Volumn 30, Issue 24, 2012, Pages 3595-3602

  Jimenez Jorge S ^a,b   Savulescu, C ^a   Pozo, F ^c   de Mateo, S ^a,b   Casas, I ^c   Ledesma, J ^c   Larrauri, A ^a,b  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Case control studies; Influenza vaccine; Sentinel system; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; FLU LIKE SYNDROME; HUMAN; INFANT; INFECTION RATE; INFLUENZA A (H1N1); INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SPAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; SPAIN; YOUNG ADULT;

EID: 84861012996     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.03.048     Document Type: Article

References (37)

1. Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Further observations. Epidemiologic Reviews 1988;10:212-41. Available from: http://epirev.oxfordjournals.org/content/10/1/212.full.pdf%B1html%3Fijkey=44c83a364466d8ecf93c0e8478b6b51009841e8a%26keytype2=tf_ipsecsha.
2. Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, et al. Field evaluation of vaccine efficacy. Bulletin of the World Health Organization 1985;63(6):1055-68. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2536484/pdf/bullwho00089-0084.pdf.
3. World Health Organization. Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season. Available from: http://www.who.int/csr/disease/influenza/201002_Recommendation.pdf.
4. Ministry of Health and Social Policy, Spain. Prevención de la gripe. Recomendaciones de vacunación antigripal [Influenza prevention. Recommendations for influenza vaccination]. Available from: http://www.msps.es/ciudadanos/enfLesiones/enfTransmisibles/gripe/home.htm.
5. Valenciano M, Ciancio B, Moren A. First steps in the design of a system to monitor vaccine effectiveness during seasonal and pandemic influenza in EU/EEA Member States. Euro Surveillance 2008;13(43). Available from: http://www.eurosurveillance.org/images/dynamic/EE/V13N43/art19015.pdf.
6. Savulescu C., Valenciano M., de Mateo S., Larrauri A. Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network - pilot case-control studies using different control groups, 2008-2009 season, Spain. Vaccine 2010, 28(16):2903-2907.
7. Savulescu C, Jimenez-Jorge S, De Mateo S, Pozo F, Casas I, Perez-Brena P, et al. Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case controls studies, Spain, season 2009-2010. BMC Public Health 2011. Available from: http://www.biomedcentral.com/content/pdf/1471-2458-11-899.pdf.
8. Savulescu C, Jimenez-Jorge S, de Mateo S, Ledesma J, Pozo F, Casas I, et al. Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control study. Euro Surveillance 2011;16(11):1-6. Available from: http://www.eurosurveillance.org/images/dynamic/EE/V16N11/art19820.pdf.
9. Spanish National Institute of Statistic. Censo de Población y Viviendas 2001. [Census of Population and Housing 2001]. Available from: http://www.ine.es/inebmenu/mnu_cifraspob.htm.
10. European Commission. European Commission Commission Decision of 30 April 2009 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council, Luxembourg: Publications Office of the European Union. 1.5.2009. L 110/58. Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do%3Furi=OJ%3AL%3A2009%3A110%3A0058%3A0059%3AEN%3APDF.
11. StataCorp.2009 Stata Statistical Sofware: Release 11 2009, StataCorp LP, College Station, TX, [computer program].
12. Centro Nacional de Epidemiología. Instituto de Salud Carlos III. Informe anual de gripe de la temporada 2010-2011 (Desde la semana 40/2010 hasta la semana 20/2011). Vigilancia de la Gripe en España. Sistema centinela. Available from: http://vgripe.isciii.es/gripe/documentos/20102011/InformesAnuales/Informe_GRIPE_Temporada_2010-11_07092011.pdf.
13. Kissling E, Valenciano M, Cohen JM, Oroszi B, Barret AS, Rizzo C, et al. I-MOVE Multi-centre Case Control Study 2010-11: Overall and Stratified Estimates of Influenza Vaccine Effectiveness in Europe. PLoS ONE 2011. Available from: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0027622.
14. Pebody R, Hardelid P, Fleming D, McMenamin J, Andrews N, Robertson C, et al. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Euro Surveillance 2011;16(6):1-6. Available from: http://www.eurosurveillance.org/images/dynamic/EE/V16N06/art19791.pdf.
15. Castilla J, Moran J, Martinez-Artola V, Reina G, Martinez-Baz I, Garcia CM, et al. Effectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis. Euro Surveillance 2011;16(7):1-6. Available from: http://www.eurosurveillance.org/images/dynamic/EE/V16N07/art19799.pdf.
16. Castilla J., Martinez-Artola V., Salcedo E., Martinez-Baz I., Cenoz M.G., Guevara M., et al. Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: Cohort and case-control study. Vaccine 2012, 30(2):195-200.
17. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. The Lancet Infectious Diseases 2011. Available from: http://www.sciencedirect.com/science/article/pii/S147330991170295X.
18. Puig-Barbera J., Arnedo-Pena A., Pardo-Serrano F., Tirado-Balaguer M.D., Perez-Vilar S., Silvestre-Silvestre E., et al. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellon, Spain. A test-negative, hospital-based, case-control study. Vaccine 2010, 28(47):7460-7467.
19. Cheng A.C., Kotsimbos T., Kelly H.A., Irving L.B., Bowler S.D., Brown S.G., et al. Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: a test-negative case control study. Vaccine 2011, 29(43):7320-7325.
20. Valenciano M, Kissling E, Cohen JM, Oroszi B, Barret AS, Rizzo C, et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study. PLoS Medicine 2011;8(1):e1000388. Available from: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000388.
21. Hardelid P, Fleming DM, McMenamin J, Andrews N, Robertson C, Sebastianpillai P, et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveillance 2011;16(2):1-7. Available from: http://www.eurosurveillance.org/images/dynamic/EE/V16N02/art19763.pdf.
22. Van Buynder P.G., Dhaliwal J.K., Van Buynder J.L., Couturier C., Minville-Leblanc M., Garceau R., et al. Protective effect of single-dose adjuvanted pandemic influenza vaccine in children. Influenza and Other Respiratory Viruses 2010, 4(4):171-178.
23. Shay D., Belongia E.A., Monto A.S., Treanor J., Talbot H.K., Gargiullo P. Effectiveness of U.S. influenza A (H1N1) 2009 monovalent vaccines in preventing healthcare visits associated with RT-PCR-confirmed 2009 H1N1 infections. Options for the control of influenza VII 2010, vol. 576. p. 392.
24. Fleming D.M., Andrews N.J., Ellis J.S., Bermingham A., Sebastianpillai P., Elliot A.J., et al. Estimating influenza vaccine effectiveness using routinely collected laboratory data. Journal of Epidemiology and Community Health 2010, 64(12):1062-1067.
25. Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric M, Li Y, et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007; 25(15):2842-51. Available from: http://www.sciencedirect.com/science/article/pii/S0264410X06011054.
26. Belongia E.A., Kieke B.A., Donahue J.G., Greenlee R.T., Balish A., Foust A., et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. The Journal of Infectious Diseases 2009, 199(2):159-167.
27. Gilca V., De Serres G., Hamelin M.E., Boivin G., Ouakki M., Boulianne N., et al. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children. Vaccine 2011, 30:35-41.
28. Health Protection Agency (UK). Surveillance of influenza and other respiratory viruses in the UK 2010-2011 report. Available from: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1296687414154.
29. Ohmit SE, Victor JC, Rotthoff JR, Teich ER, Truscon RK, Baum LL, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 2006;355(24):2513-22. Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa061850.
30. Fielding JE, Grant KA, Papadakis G, Kelly HA. Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008. BMC Infectious Diseases 2011;11:170-8. Available from: http://www.biomedcentral.com/content/pdf/1471-2334-11-170.pdf.
31. Foster DA, Talsma A, Furumoto-Dawson A, Ohmit SE, Margulies JR, Arden NH, et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. American Journal of Epidemiology 1992;136(3):296-307. Available from: PM:1415151.
32. Baxter R, Lee J, Fireman B. Evidence of bias in studies of influenza vaccine effectiveness in elderly patients. The Journal of Infectious Diseases 2010;201(2):186-9. Available from: http://jid.oxfordjournals.org/content/201/2/186.full.pdf%B1html.
33. Orenstein EW, De Serres G, Haber MJ, Shay DK, Bridges CB, Gargiullo P, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. International Journal of Epidemiology 2007;36(3):623-31. Available from: http://ije.oxfordjournals.org/content/36/3/623.full.pdf%B1html.
34. Hak E, Verheij TJ, Grobbee DE, Nichol KL, Hoes AW. Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications. Journal of Epidemiology and Community Health 2002;56(12):951-5. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1756997/pdf/v056p00951.pdf.
35. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. International Journal of Epidemiology 2006;35(2):337-44. Available from: http://ije.oxfordjournals.org/content/35/2/337.full.pdf%B1html.
36. Comstock G.W. Evaluating vaccination effectiveness and vaccine efficacy by means of case-control studies. Epidemiologic Reviews 1994, 16(1):77-89.
37. Hien TT, Boni MF, Bryant JE, Ngan TT, Wolbers M, Nguyen TD, et al. Early pandemic influenza (2009 H1N1) in Ho Chi Minh City, Vietnam: a clinical virological and epidemiological analysis. PLoS Medicine 2010;7(5):1-11. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872648/pdf/pmed.1000277.pdf.